Outset Medical, Inc. Deferred Revenue Recognized
Outset Medical, Inc. (OM) reported Deferred Revenue Recognized of $4.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-08-06
- Outset Medical, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-06-30 was $4.70M, a 0.00% change year-over-year.
- Outset Medical, Inc. contract with customer, liability, revenue recognized for the quarter ending 2026-03-31 was $5.40M, a 8.47% decline year-over-year.
- Outset Medical, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $2.00M, a 0.00% change year-over-year.
- Outset Medical, Inc. contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $4.70M, a 42.42% increase year-over-year.
- Outset Medical, Inc. contract with customer, liability, revenue recognized for fiscal 2025 was $11.20M, a 3.45% decline from fiscal 2024.
- Outset Medical, Inc. contract with customer, liability, revenue recognized for fiscal 2024 was $11.60M, a 33.33% increase from fiscal 2023.
- Outset Medical, Inc. contract with customer, liability, revenue recognized for fiscal 2023 was $8.70M, a 38.10% increase from fiscal 2022.
- Outset Medical, Inc. contract with customer, liability, revenue recognized for fiscal 2022 was $6.30M, a 96.88% increase from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.70M 10-Q · filed 2026-08-06 | $10.10M 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $5.40M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $11.20M 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-10 | $10.20M 10-Q · filed 2025-11-10 | ||
| 2025-06-30 | $4.70M 10-Q · filed 2025-08-07 | $10.60M 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $5.90M 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $11.60M 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $2.00M 10-Q · filed 2024-11-07 | $10.90M 10-Q · filed 2024-11-07 | ||
| 2024-06-30 | $3.30M 10-Q · filed 2024-08-08 | $8.80M 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | $5.60M 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $8.70M 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $1.70M 10-Q · filed 2023-11-08 | $7.90M 10-Q · filed 2023-11-08 | ||
| 2023-06-30 | $2.40M 10-Q · filed 2023-08-03 | $6.20M 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | $3.80M 10-Q · filed 2023-05-04 | |||
| 2022-12-31 | $6.30M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $1.50M 10-Q · filed 2022-11-09 | $5.80M 10-Q · filed 2022-11-09 | ||
| 2022-06-30 | $1.70M 10-Q · filed 2022-08-02 | $4.20M 10-Q · filed 2022-08-02 | ||
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $3.20M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $400.00K 10-Q · filed 2021-11-04 | $3.00M 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | $1.00M 10-Q · filed 2021-08-06 | $2.60M 10-Q · filed 2021-08-06 | ||
| 2021-03-31 | $2.40M 10-Q · filed 2021-05-06 | |||
| 2020-12-31 | $900.00K 10-K · filed 2023-02-13 | |||
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-12 | $800.00K 10-Q · filed 2020-11-12 | ||
| 2019-12-31 | $300.00K 10-K · filed 2022-02-23 | |||
| 2018-12-31 | $300.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |